American Society of Andrology (ASA) 43rd Annual Conference is organized by American Society of Andrology (ASA) and will be held during Apr 21 - 24, 2018 at The Nines, Portland, Oregon, United States of America.
The target audience for this medical event is Practicing community and academic urologists, Ph.D. researchers, graduate students, andrology lab personnel, physician extenders in fertility and urology practices, D.V.M. practitioners and candidates with reproductive focus. This CME Conference has been approved for a maximum of 26.00 AMA PRA Category 1 Credits.
Course Description :
The diagnosis and management of many conditions in andrology have been greatly influenced by recent pharmacological, surgical and basic science advances. One of the greatest challenges in this discipline is to keep abreast of the many dynamic changes in this field. An internationally acclaimed faculty has been assembled to provide this update, with presentations on topics such as Standardization of Sperm Morphology, Emerging Clinical Research and Technologies for Human Spermatogonial Stem Cells, Male Contraception, Male Infertility, Viruses in Human and Transmission of viruses after Disease Recovery, Environmental Influences on Male Reproduction and Reconstituting Andrologic Function after Traumatic Injury to Brain and Body. During the plenary sessions, attendees will have the opportunity to participate in question and answer sessions.
Course Objectives :
At the conclusion of the ASA 43rd Annual Conference, attendees will be able to:
• Explain the significance of sperm morphology to fertility outcomes.
• Describe the history of sperm morphology classification.
• Identify the problem of overly stringent classification of morphologically normal sperm.
• Learn a method of classification that is rational, repeatable and defined.
• Prescribe to become less strict in classification and reproduce WHO 5 reference values.
• Restore predictive value in sperm morphology.
• Present the types and sources of blast injuries relevant to male reproductive health.
• Discuss the challenges involved in treating these injuries.
• Review current and future areas of research in the prevention and treatment of traumatic blast injuries.
• Describe the purpose and goals of the TOUGH Project.
• Analyze the data that has been collected from the TOUGH project thus far and its significance with respect to andrology effects and outcomes; outline the protocols that have been developed in response to the findings of the study.
• Discuss the central effects of TBI as they relate to hormonal perturbations and male reproductive potential and describe interventions being implemented on the basis of this knowledge.
• Outline future areas of research to address the acute and chronic effects of TBI on male genital health and reproductive capacity.
• Outline the challenges in maintaining or restoring fertility in the face of severe testicular injury and tissue loss.
• Describe currently available means of preserving testis tissue.
• Describe current and future efforts to create germ cells from stem cell precursors.
• Discuss male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
• Demonstrate the feasibility of mixture risk assessment using data from 67 pesticides in a joint FAO/WHO case study.
• Discuss the effects of common pesticides on prostaglandin D2 inhibition and COX-2 activity in mouse Sertoli cells.
• Analyze the data that asks whether we can explain declining male reproductive health with known antiandrogens.
• Discuss how sexual transmission of Zika and Ebola viruses are similar and different from that of HIV.
• Explain the scientific strategies for developing Ebola virus vaccines.
• Explain the scientific strategies for developing Zika virus vaccines.
• Identify current research and clinical trials for Ebola and Zika virus vaccines.
ASA Clinical Symposium - Transformations: Andrology and Transgender Medicine
Educational Needs :
With an increased appreciation of the prevalence of gender dysphoria or gender -incongruent individuals in the pediatric and adult populations in the United States and beyond, a number of multidisciplinary programs have been established to provide the necessary gender-affirming medical, psychiatric and surgical care that those affected require to successfully transition to their desired gender. The rapid development of the field of Transgender Medicine has not permitted practitioners not directly involved in transgender care to acquire an understanding of the endocrinologic and surgical interventions critical to a successful transition. This in-depth seminar covering the latest iteration of the Endocrine Society’s Clinical Practice Guideline as well as state-of-the-art gender-affirming surgical procedures will impart a solid understanding of all aspects of transgender care, as it is anticipated that many urologists, general practitioners, internists, endocrinologists and others not previously exposed to transgender medicine will have clinical interactions with transgender individuals in the future.
As part of the preparation to transition, there is often a desire to maintain fertility potential which requires obtaining and freezing gametes for later use in fertility procedures. How this is accomplished is of interest to those in the andrology community and will be addressed during the course of the symposium.
Educational Objectives :
At the conclusion of the ASA Clinical Symposium, attendees should be able to:
• Review the terminology of transgender medicine.
• Define gender dysphoria and how it is diagnosed.
• Outline endocrine considerations in abetting transition from adolescence to advanced adulthood.
• Describe the preparations needed before gender-affirming procedures can be performed in Male to Female (MTF) and Female to Male (FTM) transition.
• Describe the various gender-affirming procedures, complications, and outcomes.
• Explain the lack of correlation between gender identity and sexual preference.
• Explore key aspects of transgender sexuality.
• Identify the long-term medical needs of transgender individuals.
Additional details will be posted as soon as they are available.
|Contact No.||:||+1 847-517-1050,
|Registration Type||End Date||Price|
|Non Member - Early Fee||28 Mar,2018||USD 650.00|
|Non Member - Regular Fee||09 Apr,2018||USD 710.00|
|Nonmember Student/Trainee - Early Fee||28 Mar,2018||USD 250.00|
|Nonmember Student/Trainee - Regular Fee||09 Apr,2018||USD 275.00|
|ASA Member - Early Fee||28 Mar,2018||USD 450.00|
|ASA Member - Regular Fee||09 Apr,2018||USD 510.00|
|ASA Emeritus Member - Early Fee||28 Mar,2018||USD 75.00|
|ASA Emeritus Member - Regular Fee||09 Apr,2018||USD 75.00|
|ASA Trainee Member - Early Fee||28 Mar,2018||USD 150.00|
|ASA Trainee Member - Regular Fee||09 Apr,2018||USD 175.00|
|Industry Employee - Supporting/MSL - Registration Fee||09 Apr,2018||USD 710.00|
|Industry Employee - Non-Supporting - Registration Fee||09 Apr,2018||USD 875.00|
|Andrology Lab Workshop - ASA Member (Active or Trainee) - Registration Fee||09 Apr,2018||USD 295.00|
|Andrology Lab Workshop - Nonmember - Registration Fee||09 Apr,2018||USD 345.00|
|Basic Science Workshop - Registration Fee||09 Apr,2018||USD 50.00|
|ASA Clinical Symposium - Trainee - Early Fee||28 Mar,2018||USD 50.00|
|ASA Clinical Symposium - Trainee - Regular Fee||09 Apr,2018||USD 75.00|
|ASA Clinical Symposium - Attendee - Early Fee||28 Mar,2018||USD 75.00|
|ASA Clinical Symposium - Attendee - Regular Fee||09 Apr,2018||USD 100.00|
|ASA Clinical Symposium - General Public - Registration Fee||09 Apr,2018||USD 25.00|